HOME › Press Releases › Cell Expansion Market worth 18.76 Billion USD by 2021
Cell Expansion Market worth 18.76 Billion USD by 2021
The report "Cell Expansion Market by Product (Reagent, Media, Flow Cytometer, Centrifuge, Bioreactor), Cell Type (human, animal), Application (Regenerative Medicine & Stem Cell Research, Cancer), End user (Research Institute, Cell Bank) - Global Forecasts to 2021", report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the cell expansion market along with the estimates and forecasts of the revenue and market share analysis.
Browse 168 market data tables with 48 figures spread through 189 pages and in-depth TOC on "Cell Expansion Market by Product (Reagent, Media, Flow Cytometer, Centrifuge, Bioreactor), Cell Type (human, animal), Application (Regenerative Medicine & Stem Cell Research, Cancer), End user (Research Institute, Cell Bank) - Global Forecasts to 2021"
Early buyers will receive 10% customization on reports.
The global cell expansion market is expected to reach USD 18.76 Billion by 2021 from USD 8.34 Billion in 2016 at a CAGR of 17.6% from 2016 to 2021. The major factors driving the growth of this market are increasing government funding for research, high prevalence of chronic diseases, rising company investments for the development of cell-based products, and growing number of GMP-certified production facilities.
The report segments this market based on product, cell type, application, end user, and region. Among products, the consumables segment is expected to account for the largest share of the market. The consumables market includes reagents, media and sera, and disposables. Disposables are further classified into tissue culture flasks, bioreactor accessories, and other disposables. The reagents, media, and sera segment is projected to grow at the highest CAGR from 2016 to 2021 due to increasing investments for cell-based research.
On the basis of cell type, the cell expansion market is segmented into human cells and animal cells. The human cells segment is expected to account for the largest share of the global cell expansion market in 2016. This segment is expected to grow at the highest rate due to increasing research investments by public and private organizations. Human cells include stem cells and differentiated cells. The stem cells segment is classified into adult stem cells, embryonic stem cells, and induced pluripotent stem cells.
The applications segments included in the cell expansion market are regenerative medicine and stem cell research, cancer and cell-based research, and others. The regenerative medicine and stem cell research segment is expected to account for the largest share of the global cell expansion market in 2016. Increasing investments by companies for the development of cell-based therapies are driving the growth of this market.
End users included in the cell expansion market are research institutes, biopharmaceutical and biotechnology companies, cell banks, and others. The research institutes segment is expected to account for the largest share of the global cell expansion market in 2016. The increasing prevalence of diseases and rising government investments for R&D will drive the growth of this market.
Based on region, the global cell expansion market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth in this segment is driven by increasing government funding for cell-based research.
Key players in the cell expansion market include Beckman Coulter, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Corning, Inc. (U.S.), GE Healthcare (U.K.), Lonza (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), STEMCELL Technologies, Inc. (Canada), Terumo BCT, Inc. (U.S.), and Thermo Fisher Scientific, Inc. (U.S.).
MarketsandMarkets is the world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India